Simulated annealing based algorithm for identifying mutated driver pathways in cancer

Hai-Tao Li1, Yu-Lang Zhang2, Chun-Hou Zheng3

  • 1College of Information and Communication Technology, Qufu Normal University, Rizhao 276826, China.

Insights

This study presents a new computational method to identify cancer driver pathways by distinguishing functional mutations from passenger mutations using gene expression and mutation data. The enhanced approach proves efficient and applicable to real biological datasets.

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Next-generation sequencing enables large-scale cancer genomics.
  • Distinguishing driver mutations from passenger mutations is a key challenge in cancer research.

Purpose of the Study:

  • To introduce a modified method for the maximum weight submatrix problem to identify cancer driver pathways.
  • To enhance an integrative model combining gene mutation and expression data.

Main Methods:

  • Modified maximum weight submatrix algorithm.
  • Integration of gene mutation and expression data.
  • Evaluation on simulated and real biological datasets.

Main Results:

  • The proposed method demonstrates higher efficiency compared to existing approaches on simulated data.
  • The method is successfully applied to real biological datasets, showing practical applicability.

Conclusions:

  • The developed method effectively identifies cancer driver pathways.
  • This approach aids in distinguishing functional mutations crucial for cancer development.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K